On Friday, October 2, 2020, I will be discussing hemp business law along with my colleague, Tyler Russell, and Professor Marne Coit of NC State University for a Continuing Legal Education (CLE) seminar. I hope you can join us.
Category: States’ Commerce
HIA and RE Botanicals Sue DEA Over Hemp Rule
HIA and RE Botanicals filed a legal action against the DEA on Friday regarding the Interim Final Rule it issued on August 21, 2020. We are proud to be part of the legal team.
Watch Rod on the Cannabinoid Connect Podcast (Video)
I recently had a wide-ranging discussion about cannabinoids, hemp, and marijuana with Kevin Carrillo of the Cannabinoid Connect podcast. Watch it here.
Rod Kight on the “Plants to Plants” Hemp Processing Seminar (Video)
Rod Kight discusses hemp with Emmett McGregor of SciPhy Systems for the season finale of the “Plants to Plants” hemp processing seminar series.
Oregon Hemp- An Overview of ODA Rules
The key takeaway is that transparency is rewarded. The ODA monitoring program will consist largely of education and outreach, and will start with random site record keeping visits.
Medical Cannabis and Workers’ Compensation
Workers’ compensation cases are likely to continue highlighting the tension between federal and state cannabis laws.
Medical Cannabis Clinical Evidence Is Becoming Immune To State Borders
A physician’s education about cannabis medicine, and her patient’s treatment options, should not depend on their state of residence. Patient access should be based on sound science and physicians should receive comprehensive and uniform education regardless of the state in which they practice.
NC State University Promotes Hemp In Recent Article
This month’s NC State University magazine features hemp on its cover and includes a story about hemp in NC. I am pleased that it mentions several of my clients and provides a helpful overview of the impact that hemp is having on state and national economies.
Are Oregon Cannabis Dispensaries Offering an Essential Service?
If cannabis stores close, the state of Oregon would be depriving many patients who rely on retail cannabis stores access to their medicine. If retail cannabis stores remain open, does it make sense to limit access to medicinal patents?